Swiss pharma giant Roche and its member company Genentech have partnered with US-based medical data management company Flywheel to accelerate the discovery and development of novel personalized drugs. The terms and financial details of the partnership have not been disclosed.
The partnership will leverage Flywheel’s machine learning-based research data management platform to automate data collection as well as classify and analyze medical imaging data that is collected from a variety of sources including radiology scans, digital pathology programs, and electronic health records.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.